Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MDSeventh Series 2012 - SOLACI 2012, Mexico D.F, Mexico26 / 10 / 2015Recent Advances in the Evaluation of the TAVI Candidate Alfonso Medina, MD
EuroPCR 2024 | 2 Year Outcomes of the New Sirolimus Eluting Bioadaptor vs Resolute Onyx Zotarolimus Elulting Stent
EuroPCR 2024 | NOTION-2: TAVI vs SAVR, Randomized Study on Low-Risk Young Patients with Severe Tricuspid Disease or Bicuspid Stenosis